-
Published 5/14/2025
Nordestgaard AT, Pradhan AD, Everett BM, MacFadyen JG, Bhatt DL, Visseren FLJ, Libby P, Santos RD, Nissen SE, Nordestgaard BG, Ridker PM. Expanding the triglyceride range in clinical trials: therapeutic opportunities. Eur Heart J. 2025 May 14; 46(19):1835-1848. PMID: 39950981.
-
Published 4/8/2025
Tobias DK, Pradhan AD, Duran EK, Li C, Song Y, Buring JE, Cook NR, Mora S, Manson JE. Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial. Nat Commun. 2025 Apr 08; 16(1):3332. PMID: 40199888.
-
Published 11/2/2024
Qian F, Guo Y, Li C, Liu Y, Luttmann-Gibson H, Gomelskaya N, Demler OV, Cook NR, Lee IM, Buring JE, Larsen J, Boring J, McPhaul MJ, Manson JE, Pradhan AD, Mora S. Biomarkers of glucose-insulin homeostasis and incident type 2 diabetes and cardiovascular disease: results from the Vitamin D and Omega-3 trial. Cardiovasc Diabetol. 2024 Nov 02; 23(1):393. PMID: 39488682.
-
Published 4/26/2023
Burger PM, Pradhan AD, Dorresteijn JAN, Koudstaal S, Teraa M, de Borst GJ, van der Meer MG, Mosterd A, Ridker PM, Visseren FLJ. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations. Am J Cardiol. 2023 Jun 15; 197:13-23. PMID: 37218417.
-
Published 4/25/2023
Malick WA, Waksman O, Do R, Koenig W, Pradhan AD, Stroes ESG, Rosenson RS. Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies: JACC Focus Seminar 3/3. J Am Coll Cardiol. 2023 Apr 25; 81(16):1646-1658. PMID: 37076219.